HomeNewsBusinessStoryboard18 | ‘We like buying brands... especially in the OTC space,’ Nandini Piramal

Storyboard18 | ‘We like buying brands... especially in the OTC space,’ Nandini Piramal

Nandini Piramal, executive director of Piramal Enterprises Ltd, on plans for the company’s growing consumer products division and its global brand positioning strategy for Piramal Pharma.

March 15, 2022 / 11:40 IST
Story continues below Advertisement
Nandini Piramal, executive director of Piramal Enterprises Ltd.
Nandini Piramal, executive director of Piramal Enterprises Ltd.

Over the past few years, the Piramal Group has shifted its focus to building a consumer pull for its brands, and aims to generate a turnover Rs 1,000 crore in three years from its consumer products division (CPD).

In an exclusive conversation with Storyboard18, Nandini Piramal, executive director of Piramal Enterprises Ltd, shares the company’s plans and ambitions for the CPD business as it invests in marketing and onboards a host of celebrity brand endorsers. We dive into Piramal’s playbook - growth strategy, global positioning of the pharma company brand and future plans. Edited excerpts:

Story continues below Advertisement

You set a target of Rs 1,000 crore turnover from the CPD business in the next three years. What are the key points in the plan to get there and what are the challenges that you foresee?

When we started this business and we separated it from the broader pharma business it was only Rs 65 crore. So it's tiny. Over the last 10 years we've actually grown it, we've invested in new brands. Our baby brand Little’s crossed Rs100 crore in sales. We've now invested in categories which are bigger. The baby business alone, in India, is more than Rs25,000 crore. And we’re a young country, we’re a growing country.